Owing to the well-coordinated operations of our sites in Hungary, our extensive network of external markets, and our subsidiaries and offices operating in 17 countries, we are able to contribute to the treatment of more than 30 million patients. Our most important markets are the Central Eastern European region, Russia, and the Commonwealth of Independent States.

In 18 of these countries our products are available under Egis’ brand names through our network, subsidiaries and representative offices. In these countries more than 30 million patients have been treated with Egis medicines yearly.
The company’s presence focuses on Hungary, Russia, CEE and CIS countries and Vietnam.

Since the establishment of the company more than 110 years ago, we have become one of the most significant operators in the Hungarian pharmaceutical market. Based on the number of boxes sold, we have been one of the top 3 suppliers in Hungary.

Although our main therapeutic areas are the cardiovascular and central nervous system diseases, we also provide modern treatment solutions in the fields of  diabetology, dermatology and wound care.